myVisionTrack™ is an accurate, portable, and user-friendly system that enable patients with retinal diseases to quickly and efficiently monitor their own vision function at home.

By using proprietary VAS software and a shape discrimination test implemented on a handheld electronic platform, myVisionTrack™ allows patients with degenerative eye disease such as diabetic retinopathy (DR) and Age Related Macular Degeneration (AMD) to quickly and accurately test their own visual function at home.

In the past decade, new therapies have been developed for these degenerative eye diseases, but timely treatment is critical to their effectiveness. Unfortunately most patients are unable to self-detect the renewed disease activity with the paper eye charts (Amsler Grid) which are today’s standard. There is a very large need for an easy, quick and accurate test which patients can use to monitor their own disease progression.

Patients can self-monitor their condition at home. Results of the test are stored, automatically compared with prior test results, and may be sent to a physician’s office or central service if a statistically significant change has occurred. Patients can now have peace of mind and take more responsibility in monitoring and managing their disease.

© 2011-2014 Vital Art and Science Inc. All Rights Reserved

myVisionTrack™ now FDA Cleared!

myVisionTrack™ now FDA Cleared!

Vital Art and Science Receives FDA Clearance for myVisionTrack™ Medical Device that Monitors Retinal Diseases

DALLAS, TX. (April 5, 2013) – Vital Art and Science Inc. (VAS) has received U.S. Food and Drug Administration (FDA) clearance to market myVisionTrack™, a prescription-only medical device that enables patients with retinal diseases to monitor their vision function between regular visits to their eye-care professional to help ensure they obtain timely care and treatments.

Read More about the Press Release HERE